Virtus Pharmaceuticals Recalls Extra-Virt Plus DHA Prenatal Softgels
Virtus Pharmaceuticals is recalling 2,406 bottles of Extra-Virt Plus DHA Prenatal/Postnatal Softgels because the API manufacturer is on FDA Import Alert.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Virtus Pharmaceuticals OPCO II L is recalling 2,406 bottles of Extra-Virt Plus DHA Prenatal/Postnatal Softgels, a prescription multivitamin/mineral dietary supplement with fish-based DHA. The product is packaged in 30-count bottles and is identified by NDC 76439-251-30. The specific lot affected is 21511137, with an expiration date of 10/30/2017.
The recall was initiated due to Current Good Manufacturing Practice (cGMP) deviations. Specifically, the Active Pharmaceutical Ingredient (API) manufacturer is currently on FDA Import Alert. The agency has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
The affected product was distributed nationwide. Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product matches the recall details, it should be returned to the pharmacy or point of purchase for a refund or replacement, or disposed of according to local regulations.
The recalled product
- Product
- Extra-Virt Plus DHA Prenatal/Postnatal Softgel, Prescription Multivitamin/Mineral Dietary Supplement with Fish-Based DHA , packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-251-30
- Manufacturer
- VIRTUS PHARMACEUTICALS OPCO II L
- Category
- Drug — Dietary Supplement
- Affected units
- 2,406
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots #: 21511137 Exp. date 10/30/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by VIRTUS PHARMACEUTICALS OPCO II L under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · VIRTUS PHARMACEUTICALS OPCO II L
See all →- ModerateVirtus Pharmaceuticals Recalls Virt-Select Prenatal Softgels Due to GMP Deviations
FDA (Drugs) · 2017-01-04
- LowVirt-Advance Prenatal Softgels Recalled Due to API Manufacturer Import Alert
FDA (Drugs) · 2017-01-04
- LowVirtPrex Prenatal Tablets Recalled Due to API Manufacturer Import Alert
FDA (Drugs) · 2017-01-04
- SevereVirtus Recalls Hyoscyamine Sulfate Tablets Due to Content Uniformity Failures
FDA (Drugs) · 2016-12-28
- SevereVirtus Recalls Hyoscyamine Sulfate Tablets Due to Potency Failures
FDA (Drugs) · 2016-12-28
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14
Similar recalls
- LowVirtus Pharmaceuticals Recalls Prenatal Supplement Due to Leaking Capsules
FDA (Drugs) · 2016-04-13
- LowVirtus Pharmaceuticals Recalls Leaking Prenatal/Postnatal Capsules
FDA (Drugs) · 2016-06-29
- ModerateVertical Pharmaceuticals Recalls OB Complete Prenatal Multivitamin Due to Labeling Error
FDA (Food) · 2017-05-17
- LowVirt-Nate Prenatal Supplement Recalled for Incorrect Tablet Imprinting
FDA (Drugs) · 2016-03-23
- ModerateHealthmaxx Recalls Hyper II DHA/EPA Softgels Due to Mislabeling
FDA (Food) · 2013-10-02
- ModerateConfidence Prenatal Multi-V + DHA Recalled for Undeclared Ingredients
FDA (Food) · 2018-08-22